Announcements Trials
Browse Landscape

Phase

Phase NA 11Phase 1 3Phase 3 2Phase 4 1Phase 2 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Breast Neoplasms 523Leukemia, Myeloid, Acute 499Neoplasms 381Carcinoma, Non-Small-Cell Lung 381Pancreatic Neoplasms 329Precursor Cell Lymphoblastic Leukemia-Lymphoma 319Multiple Myeloma 312Glioblastoma 311Melanoma 309Prostatic Neoplasms 293Leukemia 289Neoplasm Metastasis 284Brain Neoplasms 276Lymphoma 271Lung Neoplasms 270Recurrence 266Ovarian Neoplasms 247Colorectal Neoplasms 246Lymphoma, Non-Hodgkin 242Leukemia, Lymphocytic, Chronic, B-Cell 231Myelodysplastic Syndromes 208Glioma 208Lymphoma, Large B-Cell, Diffuse 186Carcinoma, Hepatocellular 173Lymphoma, Follicular 167Head and Neck Neoplasms 162Hodgkin Disease 160Lymphoma, Mantle-Cell 155Burkitt Lymphoma 154Sarcoma 150

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × OTHER × Parkinson Disease × Clear all
NCT01691924 2016-03-08

Study To Assess the Safety and Tolerability of PBF-509 in Male Healthy Volunteers

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Phase 1 Completed
56 enrolled

Neoplasms, Parkinson Disease

NCT02111330 2016-03-08

Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of PBF -509 (80 mg, 160 mg and 240 mg) "After Multiple Oral Doses" in Healthy Volunteers

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Phase 1 Completed
16 enrolled

Neoplasms, Parkinson Disease

NCT01698450 2014-10-09

Magnetic Resonance (MR) Guided Functional Ultrasound-Neurosurgery for Movement Disorders

University Children's Hospital, Zurich

Phase 1 Completed
10 enrolled

Dystonia, Movement Disorders, Neuralgia, Parkinson Disease, Essential Tremor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡